Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › BioMérieux Q4 Revenues Up 4 Percent

BioMérieux Q4 Revenues Up 4 Percent

Jan 23, 2018

NEW YORK (GenomeWeb) - BioMérieux reported today its fourth quarter revenues rose 4 percent year over year, with sales of BioFire FilmArray products accounting for more than half of the growth in the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

What's Popular?

In Molecular Diagnostics

  1. FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

  2. CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

  3. Quidel Preliminary Q2 Revenues Jump More Than 86 Percent

  4. Automation Helps COVID-19 Testing Scale Up, but Supply Chain Disruptions Persist

    Premium

  5. Yale, NBA Validating RNA Extraction-Free Saliva Test for Coronavirus

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.